Skip to content
★ Sign in to follow
NN
Total declarations
5
Company
1
▲ Purchases (2 ops.)
€147k
▼ Sales (1 ops.)
€25k

Latest filing published 08 Jan 2019 for Precigen, INC..

Filing timeline

BuySale
Nir Nimrodi

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
-8.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 14 Aug 2017 · 3374 days ago · €54k
    -26.2%
    Entry US$18.63 · Close at T+365 US$13.74
  • Filed 31 Aug 2016 · 3722 days ago · €93k
    -19.5%
    Entry US$25.06 · Close at T+365 US$20.17

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Nir Nimrodi: trading record in brief

This profile gathers the share dealings of Nir Nimrodi in Precigen, Inc. The record holds 5 filings, for trades running from 29 August 2016 to 4 January 2019.

The open-market side counts 2 purchases for €147k alongside 1 sale for €25k. Taken together, the purchases exceed the sales by €122k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 1 option exercise. Since January 2019: no purchases and 1 sale on the market.

The record was last updated on 8 January 2019 with a share grant in Precigen, Inc. The clock since the last published purchase (14 August 2017) now reads 3,374 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Nir Nimrodi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    Chief Business OfficerExecutivesPrecigen, Inc.
    0SEC
    13,774 sharesCommon StockSEC:0001123292-19-000129:0
  • ◇
    Chief Business OfficerExecutivesPrecigen, Inc.
    0SEC
    9,766 sharesCommon StockSEC:0001123292-19-000080:0
  • ▼
    Chief Business OfficerExecutivesPrecigen, Inc.
    28,690 USD37SEC
    4,058 shares@ US$7.07100.0% of flowCommon StockSEC:0001123292-19-000080:1
  • ▲
    SVP-Corporate DevelopmentExecutivesPrecigen, Inc.
    63,169 USD34SEC
    3,369 shares@ US$18.7531.1% of flowCommon StockSEC:0001225385-17-000098:0
    Canonical exit: 9 Nov 2017 (T+90)
  • ▲
    SVP-Corporate DevelopmentExecutivesPrecigen, Inc.
    104,480 USD16SEC
    4,000 shares@ US$26.1254.2% of flowCommon StockSEC:0001356090-16-000124:0
    Canonical exit: 27 Nov 2016 (T+90)

5 of 5 declarations